INTRODUCTION {#s1}
============

It is projected that by 2030, the number of primary total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures performed annually in the United States will increase by 174% and 673%, respectively ([@B1]). Over the same time period, the incidence of periprosthetic joint infections (PJIs) following TKA and THA is projected to increase to 6.8% ([@B2]), necessitating the treatment of approximately 272,000 patients for PJI annually. The economic burden is expected to exceed \$55 billion ([@B2]).

One of the primary mechanisms by which bacteria are thought to resist decontamination and persist as chronic infections on orthopedic devices is through the formation of biofilms. Bacteria in biofilms can be 500 to 5,000 times more resistant to antibiotic therapy than their planktonic counterparts ([@B3]). As a result, antibiotic treatments have little to no effect on the bacteria in a biofilm, making these infections extremely difficult to eradicate. Gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and Gram-negative Pseudomonas aeruginosa are two problematic pathogens of increasing concern due to their multidrug resistance ([@B4], [@B5]). These species are commonly found in life-threatening nosocomial infections, including PJI ([@B6]), creating serious and potentially untreatable clinical complications. Unfortunately, as the incidence of multidrug-resistant pathogens rises, the number of successful antibiotics on the market is diminishing. Recent reports indicate that the development of successful antibacterial drugs on the market in the United States will continue to stagnate over the coming years ([@B4]), increasing the importance of developing alternative methods of prevention and treatment of biofilm-associated infections.

Traditionally, β-lactam antibiotics are used in orthopedics for surgical prophylaxis ([@B7]), and while prophylaxis with cefazolin is most common, combined treatment with gentamicin and cefazolin or treatment with gentamicin alone has also been documented ([@B8], [@B9]). Additionally, in cases of β-lactam allergy or when a patient is colonized with MRSA, vancomycin prophylaxis is used ([@B10]). However, the growing concern over antimicrobial resistance has heightened interest in discovering alternative methods to prevent and eradicate PJI.

While the goal of surgical antimicrobial prophylaxis is to prevent PJI, infection can still develop and often requires an additional course of long-term antibiotics ([@B11]). Persistent PJIs necessitate recurrent surgical debridement and often removal of the orthopedic hardware in an attempt to aggressively eradicate the infection ([@B12]). The current gold-standard treatment for PJI is a two-stage revision. The first stage involves thorough irrigation and debridement of the surrounding tissues, exchange of the infected implant for an antibiotic-laden bone cement spacer, and a prolonged course of systemic antibiotics. This process leaves the patient biomechanically deficient until the infection is cleared and a new prosthesis can be implanted. Unfortunately, in roughly 25% of PJI patients, this treatment is ineffective ([@B10]). These persistent and refractory infections often require more drastic measures, such as joint fusion or limb amputation, for definitive treatment. Disturbingly, PJI is also associated with increased mortality, with only an 87% 5-year survival rate ([@B13]).

Titanium is commonly utilized in orthopedic and dental applications due to its high mechanical strength and excellent biocompatibility. A spontaneously forming surface oxide layer passivates the surface and provides titanium with excellent corrosion resistance. Previously, it has been shown that the faradaic and nonfaradaic electrochemical properties of commercially pure titanium (cpTi) are voltage dependent ([@B14][@B15][@B19]) and contribute to the electrochemical prevention and removal of biofilms.

Previous studies have shown that cathodic-voltage-controlled electrical stimulation (CVCES) of cpTi is a promising antimicrobial strategy to prevent and eradicate implant-associated MRSA infections ([@B15], [@B18], [@B20], [@B21]). To further investigate the potential of CVCES as a novel therapeutic for both the prevention of PJI development and the eradication of established PJIs due to multidrug-resistant pathogens, the present *in vitro* study evaluated the antimicrobial efficacy of CVCES at various magnitudes in combination with antibiotic therapy against MRSA and P. aeruginosa.

RESULTS {#s2}
=======

Eradication of bacterial biofilms using CVCES in combination with antibiotics. {#s2.1}
------------------------------------------------------------------------------

Established biofilms of MRSA strain NRS70 and P. aeruginosa strain PA27853 preformed on cpTi coupons were subjected to CVCES at −1.0 V, −1.5 V, and −1.8 V for a duration of 24 h, in the presence and absence of antibiotics, followed by assessment of bacterial viability posttreatment. All voltages are reported with respect to a chlorided silver wire (Ag/AgCl) reference electrode. The results of the eradication experiments evaluating the effects of single and combination treatments on NRS70 are shown in [Fig. 1](#fig1){ref-type="fig"}. For the −1.0-V CVCES data set, only experimental treatments containing vancomycin significantly reduced biofilm-associated and planktonic NRS70, indicating that the observed reductions are solely antibiotic mediated ([Fig. 1A](#fig1){ref-type="fig"}). CVCES alone at −1.5 V significantly reduced biofilm-associated NRS70 but had no effect on planktonic bacteria ([Fig. 1B](#fig1){ref-type="fig"}). However, CVCES at −1.5 V in combination with vancomycin produced significant and synergistic reductions in biofilm-associated NRS70 compared to all other experimental conditions. This combined treatment also showed significant reductions in planktonic NRS70 compared to controls and CVCES alone. [Figure 1C](#fig1){ref-type="fig"} shows that there were no viable biofilm-associated or planktonic NRS70 detected after CVCES at −1.8 V in both the presence and absence of vancomycin.

![Eradication of established MRSA strain NRS70 biofilms on cpTi after 24 h of CVCES in the presence or absence of vancomycin. Experiments were conducted at −1.0 V (A), −1.5 V (B), and −1.8 V (C). The conditions reported are for incubations with no stimulation (control), vancomycin alone (drug), CVCES alone (−1.0 V, −1.5 V, or −1.8 V), or CVCES with vancomycin (−1.0 V, −1.5 V, or −1.8 V plus drug). ø indicates that no detectable CFU were enumerated. Bar plots show mean values ± 1 standard deviation calculated from the four independent samples under each condition. \* indicates statistically significant differences between the groups as specified. The limit of detection is denoted with a dashed line.](mSphere.00178-19-f0001){#fig1}

Given the many differences in membrane structure between Gram-positive and Gram-negative bacteria, these CVCES parameters were further evaluated for efficacy against established biofilms of the P. aeruginosa clinical isolate PA27853 in the presence and absence of gentamicin ([Fig. 2](#fig2){ref-type="fig"}). Under the −1.0-V condition ([Fig. 2A](#fig2){ref-type="fig"}), only treatments in the presence of gentamicin reduced biofilm-associated and planktonic CFU at least 2 logs from controls. While −1.5-V CVCES alone had no significant effect on biofilm-associated or planktonic PA27853, combination treatment with gentamicin showed biologically significant reductions in biofilm-associated and planktonic PA27853 of 7 logs and 8 logs, respectively ([Fig. 2B](#fig2){ref-type="fig"}). It is further noteworthy to emphasize that combining this CVCES condition with antibiotic treatment produced synergistic reductions in biofilm-associated CFU that were significantly more robust than either of the treatments applied individually. After 24 h of CVCES at −1.8 V, there were no detectable PA27853 bacteria in both the presence and absence of gentamicin ([Fig. 2C](#fig2){ref-type="fig"}), which was consistent with the results seen for NRS70.

![Eradication of established P. aeruginosa strain PA27853 biofilms on cpTi after 24 h of CVCES in the presence or absence of gentamicin. Experiments were conducted with CVCES at −1.0 V (A), −1.5 V (B), and −1.8 V (C). The conditions reported are for incubations with no stimulation (control), gentamicin alone (drug), CVCES alone (−1.0 V, −1.5 V, or −1.8V), or CVCES with gentamicin (−1.0 V, −1.5 V, or −1.8 V plus drug). ø indicates that no detectable CFU were enumerated under the test condition. Bar plots show mean values ± 1 standard deviation calculated from the four independent samples under each condition. \* indicates a statistically significant differences between the groups as specified. The limit of detection is denoted with a dashed line.](mSphere.00178-19-f0002){#fig2}

Eradication CVCES affects medium alkalinity. {#s2.2}
--------------------------------------------

Previous reports have illustrated the relationship between microenvironment pH by electrical stimulation and its effects on bacterial viability ([@B22][@B23][@B25]). Most bacterial species have specific pH ranges (range of 2 to 3 pH units) in which growth is possible ([@B26]), and forcing the pH of the surrounding environment outside acceptable levels can induce bactericidal effects. Therefore, for all of the eradication experiments described above, pH measurements for the medium after 24 h of treatment were recorded ([Table 1](#tab1){ref-type="table"}). For each set of NRS70 and PA27853 parameters, the pH of the medium exposed to CVCES, either alone or in combination with antibiotics, increased as the applied cathodic potential increased, reaching a maximum pH of ∼12.5 with CVCES at −1.8 V. In contrast, the pH of the medium exposed to relevant controls remained fairly constant.

###### 

pH measured following eradication CVCES for NRS70 and PA27853

  Parameter[^*a*^](#ngtab1.1){ref-type="table-fn"}   Value for strain                                                           
  -------------------------------------------------- ------------------ ------------- ------------- ------------- ------------- -------------
  Mean pH ± SD under condition:                                                                                                 
      A                                              5.68 ± 0.09        5.35 ± 0.32   5.42 ± 0.24   7.43 ± 0.07   7.41 ± 0.06   7.49 ± 0.24
      B                                              7.17 ± 0.22        6.90 ± 0.22   6.73 ± 0.14   6.73 ± 0.07   6.66 ± 0.03   6.80 ± 0.07
      C                                              5.97 ± 0.24        9.13 ± 1.1    12.4 ± 0.24   7.51 ± 0.14   9.17 ± 0.13   12.6 ± 0.11
      D                                              7.84 ± 0.07        10.3 ± 0.43   12.5 ± 0.26   7.18 ± 0.19   9.70 ± 0.76   12.5 ± 0.28
                                                                                                                                
  *P* value                                                                                                                     
      A vs B                                         \<0.001            \<0.001       \<0.001       \<0.001       \<0.001       0.002
      A vs C                                         0.111              0.001         \<0.001       0.860         \<0.001       \<0.001
      A vs D                                         \<0.001            \<0.001       \<0.001       0.061         0.027         \<0.001
      B vs C                                         \<0.001            0.013         \<0.001       \<0.001       \<0.001       \<0.001
      B vs D                                         0.001              \<0.001       \<0.001       0.001         0.012         \<0.001
      C vs D                                         \<0.001            0.208         0.704         0.015         0.586         0.823

A, control; B, drug; C, CVCES; D, CVCES plus drug.

Cathodic current density and charge transfer calculated from eradication CVCES. {#s2.3}
-------------------------------------------------------------------------------

The current density is a function of the applied potential and gives information about the rate of the reactions at the electrode-electrolyte interface. At the potentials studied here, the current density indicates the rates of the oxygen and water reduction reactions. In general, the cathodic current density and cumulative charge transfers measured during the eradication experiments were shown to increase at higher cathodic potentials under all test conditions with exposure to CVCES treatment ([Table 2](#tab2){ref-type="table"}), and these increases were all significant.

###### 

Cathodic current density and cumulative charge transfer calculated from eradication CVCES

  Parameter[^*a*^](#ngtab2.1){ref-type="table-fn"}   Cathodic current density (μA/cm^2^)   Cumulative charge transfer (coulomb)                 
  -------------------------------------------------- ------------------------------------- -------------------------------------- ------------- -------------
  NRS70                                                                                                                                         
      Mean value ± SD under condition:                                                                                                          
          A                                          −3.26 ± 0.97                          −5.67 ± 0.72                           1.23 ± 0.36   2.06 ± 0.27
          B                                          −34.1 ± 4.31                          −42.4 ± 8.50                           12.8 ± 1.62   16.0 ± 3.20
          C                                          −749 ± 281                            −1248 ± 351                            282 ± 106     470 ± 132
      *P* value                                                                                                                                 
          A vs B                                     0.004                                 0.003                                  \<0.001       \<0.001
          B vs C                                     \<0.001                               \<0.001                                \<0.001       \<0.001
          A vs C                                     \<0.003                               0.003                                  \<0.001       \<0.001
                                                                                                                                                
  PA27853                                                                                                                                       
      Mean value ± SD under condition:                                                                                                          
          D                                          −2.11 ± 1.52                          −3.85 ± 1.03                           0.79 ± 0.57   1.45 ± 0.39
          E                                          −26.2 ± 5.35                          −52.0 ± 31.0                           8.28 ± 4.59   19.6 ± 11.7
          F                                          −1,156 ± 76.8                         −1,773 ± 994                           668 ± 374     436 ± 28.9
      *P* value                                                                                                                                 
          D vs E                                     0.011                                 \<0.001                                0.004         \<0.001
          E vs F                                     \<0.001                               \<0.001                                \<0.001       \<0.001
          D vs F                                     0.001                                 \<0.001                                \<0.001       \<0.001

A, −1.0 V; B, −1.5 V; C, −1.8 V; D, −1.0 V; E, −1.5 V; F, −1.8 V.

CVCES with antibiotics prevents bacterial growth and biofilm formation. {#s2.4}
-----------------------------------------------------------------------

In this series of studies, CVCES was further evaluated as a single treatment and in combination with relevant antibiotics for the ability to prevent bacterial growth, attachment, and biofilm formation on cpTi. To evaluate prevention efficacy, freshly inoculated wells containing ∼10^3^ CFU/ml of logarithmically growing bacteria and a sterile cpTi coupon were exposed for 24 h to CVCES at −1.0 V or −1.5 V in the presence or absence of antibiotics. Subsequently, CFU were enumerated for planktonic bacteria in the medium and biofilm-associated bacteria adherent to the submerged cpTi coupon. An evaluation of CVCES at −1.8 V for 24 h was not performed due to previous prevention studies showing that the application of CVCES alone at −1.8 V for 8 h had a sterilizing antimicrobial effect ([@B15]). [Figure 3](#fig3){ref-type="fig"} shows the set of prevention experiments conducted with NRS70 in the presence or absence of vancomycin. Compared to controls, CVCES alone at −1.0 V ([Fig. 3A](#fig3){ref-type="fig"}) and −1.5 V ([Fig. 3B](#fig3){ref-type="fig"}) significantly reduced the biofilm-associated CFU but had little effect on the planktonic bacteria. In contrast, the combination of −1.5-V CVCES with vancomycin completely prevented bacterial colonization and subsequent biofilm formation on the cpTi coupon and produced an additional 2-log reduction in planktonic NRS70 compared to the single-treatment controls alone.

![Prevention of MRSA strain NRS70 growth and biofilm formation on cpTi after 24 h of CVCES in the presence or absence of vancomycin. Experiments were conducted with CVCES at −1.0 V (A) or −1.5 V (B). The conditions reported are for incubations with no stimulation (control), vancomycin alone (drug), CVCES alone (−1.0 V or −1.5 V), or CVCES with vancomycin (−1.0 V or −1.5 V plus drug). ø indicates that no detectable CFU were enumerated under the test condition. Bar plots show mean values ±1 standard deviation calculated from the four independent samples under each condition. \* indicates statistically significant differences between the groups as specified. The limit of detection is denoted with a dashed line.](mSphere.00178-19-f0003){#fig3}

These prevention studies were repeated against PA27853. [Figure 4](#fig4){ref-type="fig"} depicts biofilm-associated and planktonic PA27853 CFU enumerated for the tests conducted at −1.0 V ([Fig. 4A](#fig4){ref-type="fig"}) and −1.5 V ([Fig. 4B](#fig4){ref-type="fig"}). Combination treatments evaluating gentamicin with CVCES at −1.0 V ([Fig. 4A](#fig4){ref-type="fig"}) and −1.5 V ([Fig. 4B](#fig4){ref-type="fig"}) resulted in complete inhibition of any detectable biofilm-associated bacteria adherent to the cpTi coupon and complete killing of planktonic PA27853. The reductions in biofilm-associated CFU for the combined treatments were again shown to be synergistic, as they had significantly greater antimicrobial effects than either of the individual treatments.

![Prevention of P. aeruginosa strain PA27853 growth and biofilm formation on cpTi after 24 h of CVCES in the presence or absence of gentamicin. Experiments were conducted with CVCES at −1.0 V (A) or −1.5 V (B). The conditions reported are for incubations with no stimulation (control), gentamicin alone (drug), CVCES alone (−1.0 V or −1.5 V), or CVCES with gentamicin (−1.0 V or −1.5 V plus drug). ø indicates that no detectable CFU were enumerated under the test condition. Bar plots show mean values ± 1 standard deviation calculated from the four independent samples under each condition. \* indicates statistically significant differences between the groups as specified. The limit of detection is denoted with a dashed line.](mSphere.00178-19-f0004){#fig4}

Prevention CVCES affects medium alkalinity. {#s2.5}
-------------------------------------------

[Table 3](#tab3){ref-type="table"} shows pH measurements taken after 24 h of incubation in the presence or absence of vancomycin (NRS70) and gentamicin (PA27853) for the set of prevention experiments conducted with CVCES at −1.0 V and −1.5 V. The data clearly show that exposure to CVCES produced an alkaline shift in pH that increased with the magnitude of the CVCES applied.

###### 

pH measured following prevention CVCES for NRS70 and PA27853

  Parameter[^*a*^](#ngtab3.1){ref-type="table-fn"}   Value for strain                               
  -------------------------------------------------- ------------------ ------------- ------------- --------------
  Mean pH ± SD under condition:                                                                     
      A                                              6.83 ± 0.13        6.99 ± 0.07   7.14 ± 0.14   7.08 ± 0.07
      B                                              7.07 ± 0.05        7.03 ± 0.09   7.02 ± 0.04   7.06 ± 0.045
      C                                              7.74 ± 0.25        9.96 ± 0.54   7.35 ± 0.29   9.17 ± 0.087
      D                                              8.00 ± 0.23        10.0 ± 0.38   8.07 ± 0.13   9.51 ± 0.11
                                                                                                    
  *P* value                                                                                         
      A vs B                                         0.321              0.808         0.475         0.994
      A vs C                                         \<0.001            0.000         0.587         \<0.001
      A vs D                                         \<0.001            \<0.001       \<0.001       \<0.001
      B vs C                                         0.001              0.001         0.275         \<0.001
      B vs D                                         \<0.001            \<0.001       \<0.001       \<0.001
      C vs D                                         0.238              0.956         0.032         \<0.001

A, control; B, drug; C, CVCES; D, CVCES plus drug.

Cathodic current density and charge transfer calculated from prevention CVCES. {#s2.6}
------------------------------------------------------------------------------

Cathodic current densities and cumulative charge transfer values determined from prevention experiments at −1.0 V and −1.5 V are presented in [Table 4](#tab4){ref-type="table"}. Significant differences were reported across stimulation magnitudes for both the current density and cumulative charge transfer.

###### 

Cathodic current density and cumulative charge transfer calculated from prevention CVCES

  Parameter[^*a*^](#ngtab4.1){ref-type="table-fn"}   Cathodic current density (μA/cm^2^)   Cumulative charge transfer (coulomb)                 
  -------------------------------------------------- ------------------------------------- -------------------------------------- ------------- -------------
  NRS70                                                                                                                                         
      Mean value ± SD under condition:                                                                                                          
          A                                          −5.51 ± 0.94                          −5.64 ± 1.01                           2.07 ± 0.35   2.13 ± 0.38
          B                                          −51.3 ± 34.4                          −36.5 ± 8.5                            19.3 ± 12.9   13.7 ± 3.20
      *P* value for A vs B                           \<0.001                               \<0.001                                \<0.001       \<0.001
                                                                                                                                                
  PA27853                                                                                                                                       
      Mean value ± SD under condition:                                                                                                          
          C                                          −3.7 ± 0.3                            −5.5 ± 0.70                            1.37 ± 0.12   2.09 ± 0.25
          D                                          −25.8 ± 1.27                          −27.9 ± 3.51                           9.73 ± 0.47   10.5 ± 1.32
      *P* value for C vs D                           \<0.001                               \<0.001                                \<0.001       \<0.001

A, −1.0 V; B, −1.5 V; C, −1.0 V; D, −1.5 V.

Effect of pH on planktonic and biofilm-associated NRS70 and PA27853. {#s2.7}
--------------------------------------------------------------------

Due to the suspected correlation between increased pH and decreased bacterial viability associated with CVCES, these studies were designed to determine the relationship between alkaline microenvironment pH and bactericidal effects. Here, planktonic cultures and established biofilms of NRS70 and PA27853 were exposed to medium that was chemically titrated to a range of alkaline pH values. [Figure 5](#fig5){ref-type="fig"} shows the results of incubating planktonic cultures and biofilms for 24 h in medium chemically titrated to pH 7, 8, 9, 10, 11, or 12. These data demonstrate that the NRS70 biofilms ([Fig. 5A](#fig5){ref-type="fig"}) do not show any decline in viability until pH 10 and reach an ∼4-log reduction in CFU at pH 12. In contrast, planktonic NRS70 bacteria ([Fig. 5B](#fig5){ref-type="fig"}) are more sensitive to pH, as there is an ∼4-log reduction in CFU once the pH increases to 10. There was a modest sensitivity of PA27853 biofilms ([Fig. 5C](#fig5){ref-type="fig"}) to pH 10 and a more pronounced ∼3-log decline in PA27853 biofilm viability at pH 11, which increased to an ∼7-log decline at pH 12. The PA27853 planktonic cultures ([Fig. 5D](#fig5){ref-type="fig"}) were clearly more sensitive than the biofilms, as there were no planktonic CFU detected when the medium was titrated at or above pH 10.

![Survival of MRSA strain NRS70 and P. aeruginosa strain PA27853 at alkaline pH after 24 h of exposure. Shown are CFU for NRS70 biofilm (A) and planktonic cultures (B) and PA27853 biofilm (C) and planktonic cultures (D) following exposure to medium adjusted to a pH ranging from 7 to 12 for 24 h. ø indicates that no detectable CFU were enumerated under the test condition. A minimum of 3 independent replicates were performed under each condition. The limit of detection is denoted with a dashed line. \* indicates statistically significant differences between the groups specified and the pH 7 condition.](mSphere.00178-19-f0005){#fig5}

DISCUSSION {#s3}
==========

The emergence of multidrug-resistant pathogens necessitates alternative prevention and eradication methods for PJI ([@B10], [@B27], [@B28]). MRSA and P. aeruginosa are problematic pathogens in orthopedics that have developed clinically in the presence of prophylactic surgical antibiotics and can be difficult to treat with traditional irrigation, debridement, and antimicrobial therapy. Our results align with the clinical observation that antibiotic treatment alone can be ineffective at infection eradication and prevention ([@B29], [@B30]). Notably, the outcomes of this study reveal that applying CVCES directly to cpTi for 24 h can be effective for eradicating or preventing an associated MRSA or P. aeruginosa bacterial burden and, significantly, that the bactericidal effects of CVCES can be synergistically enhanced by concurrent antibiotic treatment.

The eradication studies reported here showed that extended-duration (24-h) CVCES had more robust antimicrobial effects than in previously reported eradication studies that utilized shorter-duration (1-h) CVCES ([@B18]). Importantly, it was shown that CVCES at −1.8 V for 24 h effectively eradicated biofilm-associated and planktonic NRS70 bacterial burdens. In addition, for the first time, the present study also shows the efficacy of CVCES for eradicating Gram-negative biofilms on cpTi using P. aeruginosa as the model organism. CVCES at −1.8 V completely eradicated planktonic and biofilm-associated PA27853 after 24 h. For both organisms, the effects of CVCES alone were magnitude dependent, with higher cathodic potentials exhibiting greater reductions in viability.

Additionally, this work also expanded upon previous, shorter-duration, CVCES prevention studies ([@B15]) by extending the stimulation duration to 24 h. This extended exposure to CVCES showed 2- to 3-log reductions in biofilm-associated NRS70 after CVCES treatment at −1.0 V and −1.5 V. Interestingly, these effects were not seen for PA27853, where CVCES alone at −1.0 V and −1.5 V had no effects on biofilm or planktonic bacteria after 24 h. It is possible that the variations in the cell wall compositions of Gram-positive MRSA and Gram-negative P. aeruginosa are important factors that influence the effectiveness of CVCES alone to prevent bacterial colonization of the cpTi surfaces.

Our eradication and prevention studies utilized cpTi because titanium and its alloys are frequently used in orthopedic and dental applications due to their excellent biocompatibility, high strength, and osseointegration qualities. When CVCES is applied to cpTi in the presence or absence of antibiotics, significant increases in the pH were observed compared to the no-treatment controls ([Tables 1](#tab1){ref-type="table"} and [3](#tab3){ref-type="table"}). This increase is likely due to the production of hydroxide ions as a result of the water and oxygen reduction reactions occurring on the cpTi surface. The results of our study also indicate that higher cathodic current density, and, consequentially, greater cumulative charge transfer, occurs when higher magnitudes of CVCES were applied to cpTi ([Tables 2](#tab2){ref-type="table"} and [4](#tab4){ref-type="table"}). These larger faradaic processes were also associated with greater alkaline pH shifts of the microenvironment and more effective prevention and eradication of NRS70 or PA27853 from the surface of cpTi.

The observations from the present study, combined with previously reported CVCES outcomes ([@B15]), suggested that pH was related to the antimicrobial effects of CVCES in an exposure-time- and pH-dependent manner. The results implied that modest alkaline pH values (∼8 to 9) need extended durations (24 h) to be antimicrobial, whereas higher alkaline pH values (∼12) can be antimicrobial at shorter durations (4 to 8 h) ([@B15]). However, the effect of alkaline medium pH was further evaluated in the absence of CVCES and revealed some discrepancies between the antimicrobial effects of electrochemically generated alkaline medium pH and chemically titrated alkaline medium pH. For example, reductions in the viability of established NRS70 and PA27853 biofilms or planktonic cultures were noted only when the chemically titrated medium pH was at or above pH 10, whereas antimicrobial effects were shown at more modest electrochemically generated alkaline pH values. Furthermore, exposure to chemically titrated alkaline medium at pH 12 was unable to completely eradicate the biofilms, but complete biofilm eradication was noted when CVCES at −1.8 V electrochemically generated an alkaline medium pH of 12. These discrepancies highlight that alkaline pH alone is not solely responsible for the antimicrobial effects and that other mechanisms associated with the CVCES electrochemical processes are also likely contributing to the antimicrobial outcomes. For example, others have shown that H~2~O~2~ can be electrochemically generated at cathode surfaces and can contribute to bactericidal activity ([@B31][@B32][@B35]). Additionally, others have suggested H~2~ gas evolution as the primary mechanism responsible for the removal of a 10-day-old P. aeruginosa biofilm preformed on 316L stainless steel substrates polarized to magnitudes cathodic to −1.5 V versus Ag/AgCl ([@B36]). It is possible that H~2~ gas is produced in the −1.8-V CVCES and acts concurrently with the basic pH to mechanically disrupt the biofilm to create these differences. Another aspect to consider is that pH measurements reported in the present CVCES study were bulk pH measurements made only at the end of the 24-h tests. Therefore, the temporal and spatial profile of how the medium pH changes during the tests or how long the bacteria are exposed to these electrochemically generated alkaline pH levels is unknown. Future work will address this knowledge gap and measure the change in pH as a function of CVCES over time.

The prevention studies showed that combining CVCES with concurrent antibiotic therapy provides synergistic reductions in the number of bacteria that attach to the cpTi for both NRS70 and PA27853. Furthermore, synergistic reductions in the preformed biofilms of NRS70 and PA27853 were also evident in the eradication experiments that combined CVCES at −1.5 V with antibiotics. The synergism between electrical stimulation and antimicrobial agents has been previously documented ([@B20], [@B21], [@B33], [@B37][@B38][@B44]). Of particular relevance, antimicrobial synergy has been shown for electrical stimulation combined with vancomycin against S. aureus ([@B39]) and with tobramycin against P. aeruginosa ([@B33], [@B40][@B41][@B42], [@B44]). However, there are important differences to highlight in the experimental protocols between the present study and those previous studies. Many of those previous studies assessed the effects of electrical stimulation by bringing the stimulating electrodes in proximity to biofilms formed on the surface of other materials ([@B33], [@B39], [@B40], [@B44]). In the present study, the cpTi coupons on which bacterial interactions were assessed were also utilized as the stimulating electrode. This emphasizes the role of interfacial electrochemistry in our study and importantly mimics what would be done clinically if electrical stimulation was applied directly to metallic implants for infection control. Furthermore, many previous studies have utilized current-controlled electrical stimulation delivered via a two-electrode configuration that exposed bacteria to both oxidation and reduction processes ([@B39][@B40][@B42], [@B44]), whereas the present study utilized three-electrode CVCES to assess antimicrobial effects of isolated reduction processes. Furthermore, in those previous reports, it was often necessary to use antibiotic concentrations that were well above the MIC (5-fold to 20-fold higher) to show synergy between electrical stimulation and antibiotics ([@B33], [@B39], [@B40], [@B44]). It is important to note that our studies used the MIC of each antibiotic, which resulted in a remarkable synergy in combination with CVCES. This is a significant observation given that the overuse of antibiotics is a major cause of the development of resistance. Although the MIC does not always correlate with the concentrations used in patients, it represents a conservative and translatable value to study the synergistic effects of CVCES with antibiotics. These encouraging results indicate that future studies are warranted to determine if our CVCES parameters in combination with other relevant antibiotics are as effective against a much broader range of organisms that are also associated with PJI.

Another interesting aspect of both the prevention and eradication studies was that a similar alkaline pH (∼9 to 10) was achieved when CVCES of −1.5 V was applied in both the absence and presence of the antibiotic; however, synergistic reductions in biofilm-associated CFU were reported for the combined treatment. In addition, in the prevention study, CVCES at −1.0 V, in both the presence and absence of the antibiotic, resulted in pH ∼8, but again, synergistic reductions in both biofilm-associated and planktonic CFU occurred with the combined treatment. This may indicate that the alkaline pH, either alone or in combination with other CVCES-associated electrochemical processes, modifies the antibiotics to enhance their effectiveness and/or alters the physiology of the bacteria or the structure of the biofilm, rendering it more susceptible to the antibiotic.

It has previously been shown that pH can alter biofilm structure and that biofilms can expand in thickness upon cathodic polarization of platinum substrates ([@B43]). Furthermore, polarized electrodes may disrupt the charge distribution within a biofilm and enhance the transport mechanism of charged molecules, such as antimicrobial agents, through the diffusion barrier of the biofilm matrix ([@B37][@B38][@B39]). Others have shown that significant alterations in membrane permeability, membrane potential, and intracellular reactive oxygen species occur in bacteria upon exposure to electrical stimulation ([@B33], [@B42]) and altered environmental pH ([@B45]). Furthermore, it has been documented that aminoglycoside uptake, and specifically gentamicin uptake, is heavily dependent on the transmembrane potential ([@B46][@B47][@B49]). Therefore, in the present study, it is hypothesized that the application of cathodic polarization to the cpTi may have altered the transmembrane potential of PA27853 to enhance the uptake of gentamicin compared to treatment in the absence of electrical stimulation. This also supports our finding that there was an 8-log difference in recoverable biofilm-associated and planktonic CFU with CVCES combined with gentamicin compared to CVCES alone.

In summary, we evaluated the bactericidal efficacy of CVCES at multiple levels in the presence and absence of antibiotics. CVCES at −1.8 V for 24 h showed eradication of biofilm-associated and planktonic bacteria below detectable levels for both MRSA and P. aeruginosa. While encouraging, these parameters may be restricted depending on the overall size and material of the implant. In addition, the use of CVCES in a clinical setting would most likely require the use of antibiotics to guard against possible systemic spread of bacteria that are released from biofilms. Thus, we further evaluated CVCES at lower magnitudes for longer durations in combination with relevant antibiotics to determine if this technology could be more broadly applicable. These studies confirmed that CVCES at −1.5 V for 24 h in combination with antibiotic therapy results in synergistic and significant bactericidal activity in both the eradication and prevention studies. Remarkably, CVCES at −1.5 V with antibiotic prophylaxis was able to prevent MRSA and P. aeruginosa attachment on the cpTi coupon from reaching detectable levels. Furthermore, prevention CVCES at −1.0 V in combination with vancomycin prophylaxis was able to synergistically reduce both the biofilm-associated and planktonic MRSA bacterial burdens to approximately 10^2^ CFU/ml, and the same treatment with P. aeruginosa reduced viable CFU to levels below detection.

This work shows promising future applications of CVCES for the prevention and eradication of PJI. Clinically, this CVCES technology could potentially be used for infection prevention immediately following implantation while the patient is in recovery or, in the event of PJI, could be used in lieu of a 2-stage exchange joint arthroplasty. More research is required to determine the histological effects of the extended duration of an applied voltage *in vivo*; however, previous *in vivo* studies have revealed that exposure to −1.8-V CVCES for 1 h in an *in vivo* rodent shoulder model had no deleterious histological effects on the bone or surrounding tissue following stimulation ([@B18], [@B20], [@B21]). Future considerations for human use include, but are not limited to, the size of the implant, the total current, as well as the implant material. The exact mechanisms governing the antimicrobial effects of this technology are unknown but are postulated to include a CVCES-induced faradaic modification of the surrounding microenvironment. Continued optimization of the CVCES parameters in combination with clinically relevant antibiotic therapies may provide novel and effective strategies to prevent and or eradicate PJI postimplantation.

MATERIALS AND METHODS {#s4}
=====================

Bacterial strains. {#s4.1}
------------------

Experiments were conducted using the Gram-positive bacterium MRSA, strain NRS70, a clinical respiratory isolate ([@B50]), or the Gram-negative bacterium P. aeruginosa, ATCC type strain PA27853, a clinical blood isolate. Bacteria were routinely cultured in tryptic soy broth supplemented with 0.25% glucose (TSBG) for NRS70 or Mueller-Hinton (MH) broth for PA27853 and grown at 37°C with aeration or plated on MH agar plates and incubated overnight at 37°C in 5% CO~2~ (both NRS70 and PA27853).

Coupon preparation. {#s4.2}
-------------------

Commercially pure titanium (cpTi) (grade 2; Titanium Industries, Inc.) metal coupons (0.68 cm long by 0.68 cm wide by 1.25 cm high) were wet sanded to a 600-grit finish, sonicated in deionized water for 10 min, submerged in 70% ethanol for 20 min, and sterilized under UV light for 30 min.

Chamber preparation. {#s4.3}
--------------------

Custom test chambers were fabricated by pouring hot liquid agar (1.5% pure agar) in sterile saline (0.9% NaCl, pH 7.2) into a sterile acrylic chamber ([@B15], [@B18]). Briefly, the agar chamber ([Fig. 6](#fig6){ref-type="fig"}) uses a standard three-electrode system with cpTi as the working electrode, a graphite counterelectrode, and an Ag/AgCl reference electrode. A graphite counterelectrode was placed into one of the two preformed wells, and the titanium working electrode was suspended in the remaining preformed well. The Ag/AgCl reference electrode was passed through the third port and embedded directly within the agar.

![Schematic representing the custom*-*designed three-electrode potentiostatic electrochemical stimulation chamber. An eradication CVCES setup is depicted with a preformed biofilm (green) on the cpTi working electrode. (Reprinted from reference [@B18] with permission.)](mSphere.00178-19-f0006){#fig6}

Eradication studies: biofilm preparation. {#s4.4}
-----------------------------------------

Fresh cultures were suspended in medium to an optical density at 600 nm (OD~600~) of 0.05, corresponding to approximately 10^5^ CFU/ml, and then diluted 1:1,000 to determine the inoculum. The prepared titanium coupons were placed into 50-ml conical tubes containing 5 ml of the bacterial inoculum and incubated at 37°C for 18 h at 100 rpm to allow for the development of adherent biofilms on the submerged surface of the cpTi coupon ([@B18]). The titanium coupons coated with biofilm-associated bacteria were rinsed with sterile phosphate-buffered saline (PBS) to remove loosely adherent cells and then placed into the agar chamber as the working electrode. Subsequently, 3 ml of sterile medium with or without antibiotics, as required, was added to the working electrode well, and 3 ml of sterile medium was placed into the graphite counterelectrode well.

Prevention studies: culture preparation. {#s4.5}
----------------------------------------

Fresh cultures were inoculated into 5 ml of the appropriate broth medium at a 10:1 flask-to-volume ratio, adjusted to an OD~600~ of 0.1. Cultures were grown as described above at 180 rpm to mid-log phase, diluted back to an OD~600~ of 0.1 (corresponding to approximately 10^7^ CFU/ml), and then further diluted 1:10,000 in fresh medium for a starting inoculum of approximately 10^3^ CFU/ml. Each bacterial culture was evaluated in the presence and absence of the MIC of the appropriate antibiotic. Three milliliters of the test culture, with or without the strain-specific antibiotics, was added to the working electrode well, and 3 ml of sterile medium was placed into the graphite counterelectrode well.

MIC. {#s4.6}
----

Biofilms were prepared on titanium coupons as described above for the eradication studies and incubated with various concentrations of the antibiotic. After 24 h of incubation, biofilms were then dilution plated for CFU to determine the lowest concentration of the antibiotic required for eradication studies. Concentrations of 500 μg/ml vancomycin against NRS70 biofilms and 3,000 μg/ml gentamicin against PA27853 biofilms were determined. According to Clinical and Laboratory Standards Institute (CLSI) methods for antimicrobial susceptibility testing, the MICs of planktonic vancomycin and gentamicin were evaluated. Planktonic cultures were prepared to 10^3^ CFU/ml, as described above for prevention experiments, and treated with various concentrations of the antibiotic by broth microdilution. Vancomycin has an MIC of 0.5 μg/ml against planktonic NRS70, and gentamicin has an MIC of 3 μg/ml against planktonic PA27853 ([@B51]).

Cathodic-voltage-controlled electrical stimulation. {#s4.7}
---------------------------------------------------

With respect to an Ag/AgCl reference electrode, a voltage of −1.0 V, −1.5 V, or −1.8 V for 24 h was applied to the titanium working electrode at room temperature using a potentiostat (Interface 1000; Gamry Instruments) in the presence and absence of vancomycin for both prevention and eradication experiments. No prevention testing was performed at −1.8 V due to the significant reductions observed previously after CVCES at −1.8 V for 8 h ([@B15]). Two additional conditions, antibiotic alone (i.e., no CVCES) and no-treatment controls (i.e., no CVCES and no antibiotic), were also evaluated for each experiment. Therefore, each set of eradication or prevention experiments performed for a given CVCES magnitude consisted of four experimental conditions: no-treatment controls, drug alone, CVCES alone, or CVCES and antibiotics combined. Each set of experiments was repeated four independent times for each CVCES magnitude. All voltages in this study are reported with respect to Ag/AgCl.

For PA27853 prevention and eradication experiments, in addition to adding the antibiotic to the medium in the working electrode well, the agar surrounding each of the wells was supplemented with gentamicin (3 μg/ml or 3,000 μg/ml for prevention or eradication, respectively) under antibiotic-alone and CVCES-and-drug conditions. This was done to prevent the antibiotics from diffusing from the well into the agar gel due to a concentration gradient, as had been observed in separate preliminary experiments (data not shown). Vancomycin is a large molecule, and after testing, diffusion into the agar was not observed (data not shown). Therefore, in the NRS70 prevention and eradication experiments, vancomycin was added only to the medium in the working electrode well and was not added to the agar gel because diffusion was not observed.

Enumeration of CFU. {#s4.8}
-------------------

After 24 h of incubation under the given experimental conditions, titanium coupons were washed in sterile PBS--0.1% saponin (Sigma-Aldrich, St. Louis, MO) and sonicated in 1 ml of sterile PBS--0.1% saponin for 10 min to release adherent bacteria from the surface. Surviving biofilm-associated CFU were enumerated by plating 100 µl of serial 10-fold dilutions onto Mueller-Hinton agar plates. The plates were incubated for 18 h at 37°C in 5% CO~2~. Surviving planktonic bacteria were enumerated from the cathode by collecting the medium surrounding the cpTi working electrode and plating serial dilutions as described above to determine CFU.

pH measurements. {#s4.9}
----------------

A pH electrode (Seven Easy InLab413; Mettler Toledo) was used to measure the pH of the medium surrounding the titanium working electrode following the 24-h incubation/stimulation protocol for all experiments.

Charge transfer calculations. {#s4.10}
-----------------------------

Cathodic current measurements were collected for the duration of CVCES under all conditions and averaged across treatments with and without antibiotics. The cathodic current was integrated with respect to time to determine the total charge transferred during stimulation. Using a Riemann sum trapezoidal method, calculations were performed in Microsoft Excel to determine the cumulative charge transferred during CVCES. The cathodic current was area normalized by dividing by the surface area of the working electrode and reported as cathodic current density.

Eradication and prevention pH models. {#s4.11}
-------------------------------------

TSBG and MH broth were adjusted to pH 7, 8, 9, 10, 11, and 12 with the addition of NaOH or HCl, where appropriate, and filter sterilized prior to use. pH was confirmed using a Mettler Toledo Seven Easy InLab413 pH electrode.

In the biofilm pH model, fresh cultures were suspended to an OD~600~ of 0.05, corresponding to approximately 10^5^ CFU/ml. Cultures were diluted 1:1,000 to determine the inoculum. One milliliter of the prepared culture was used to seed the bottom of polystyrene 24-well plates, and biofilms were cultured at 37°C in 5% CO~2~ for 18 h. The supernatant was then removed and replaced with 3 ml of fresh medium adjusted to pH 7 to 12. Samples were incubated for an additional 24 h at room temperature without agitation. The supernatant was removed, and biofilms were collected from each well after mechanical resuspension in 1 ml of PBS. One hundred microliters of serial 10-fold dilutions was plated onto MH agar plates to enumerate surviving bacteria. The plates were incubated for 18 h at 37°C in 5% CO~2~. Each experiment consisted of three independent samples from two pooled wells.

For planktonic pH experiments, fresh cultures were inoculated at a 10:1 flask-to-volume ratio, adjusted to an OD~600~ of 0.1, and placed in a 37°C shaking water bath at 180 rpm. Cultures were grown to mid-log phase and diluted back to an OD~600~ of 0.1. Cultures were then further diluted 1:10,000 in the appropriate fresh medium at either pH 7, 8, 9, 10, 11, or 12, for a starting inoculum of approximately 10^3^ CFU/ml for each pH assay. Under each condition, 3-ml aliquots of the pH-adjusted bacterial inocula were added to individual wells of a 24-well polystyrene dish. Samples were incubated for 24 h at room temperature without agitation. After 24 h, medium in the well was collected. One hundred microliters of serial 10-fold dilutions was plated onto MH agar plates to enumerate surviving bacteria. The plates were incubated for 18 h at 37°C in 5% CO~2~.

Statistical analysis. {#s4.12}
---------------------

One-way analysis of variance (ANOVA) followed by Tukey *post hoc* analysis, where appropriate, was used to compare the log-transformed CFU and pHs across treatment conditions (control, drug, CVCES, and CVCES with drug) for both eradication and prevention experiments. ANOVA was also used to compare the log-transformed current densities and charge transfers across stimulation conditions (−1.0 V, −1.5 V, and −1.8 V). Alternatively, if the Levene's test was significant, the data were analyzed by Welch's test followed by a Games-Howell *post hoc* test, where appropriate. For the pH incubation experiments, ANOVA followed by a Dunnett test was used to individually compare viable CFU from pH 7 to viable CFU from pH 8 to 12. In addition, Student's *t* tests were used to compare the cathodic current densities and cumulative charge transfers for the prevention experiments under −1.0-V and −1.5-V conditions. A *P* value of 0.05 was considered significant in all tests. The statistical analysis was performed with SPSS statistical software, version 12 (IBM Corp., Armonk, NY).
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